HLX04-O

· Shanghai Henlius Biotech

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for HLX04-O, covering 2023-10-23 to 2025-03-24. Get the full timeline:

Most recent: Clinical Trial Update: Compare the Efficacy and Safety of HLX04-O with Ranibizumab in Subjects with WAMD [Phase 3]